Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biochemistry
VLST Corporation Announces Board and Executive Management Appointments
March 1st, 2008
VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, announced the appointments of Dr. David L. Urdal, chief scientific officer of Dendreon Corporation (NASDAQ:DNDN), to the Company's board of directors and Mr. Ron Myers, former associate general counsel, intellectual property for Corixa Corp., as vice president, legal affairs and intellectual property. "The addition of these talented and experienced professionals to VLST's board and management comes at a time of continued advancement and growth for our Company," said Martin Simonetti, president and chief executive officer of VLST....
Source: Law & Health Weekly (2008-03-01)
|
